Clinical Trials on Lentigo in Australia
Total 2 results
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaCompletedLentigo MalignaAustralia, Brazil, New Zealand
-
Medical University of GrazUnknownLentigo MalignaAustria
Sponsors and Collaborators
- Australian Childhood Foundation
- Health Holding Company, Hail Health Cluster, Saudi Arabia
- Epicentre, Paris, France.
- NATURAmedicatrix Sàrl
- Remedy Institute
- The Depressive and Bipolar Disorder Alternative Treatment Foundation
- Sonogenix
- Brigham and Womens' Hospital, Center for Surgery and Public Health
- Kettering Foundation
- Sociedad Española de Arteriosclerosis
- Zhijun Sun
- Paul W. Read, MD
- Carlos III Health Institute
- Jain, Isha, B.A., Massachusetts General Hospital, Harvard Medical School
- Dr Gilles DUCHEIX/ Center of clinical pharmacology/CIC Inserm-501 - Investigator
- Prader-Willi Syndrome Association of Australia
- wenbinlu
- Resurge Therapeutics Inc.
- Méthodologie et Evaluation pour la Recherche clinique et Epidémiologique sur le VIH en Afrique (MEREVA)
- Laboratoires Iprad-Vegebom
- View Full List
Medical Conditions
- Stroke Recrudescence
- Stage IIIB Esophageal Adenocarcinoma
- Cell Senescence
- Neurobehavioral Manifestation
- Malignant Tumor of Extrahepatic Bile Duct
- Intervention Studies
- Pregnancy; Accident
- Mycobacterium Avium Complex Infections
- Escape Room Games and Role Playing Gamification
- Psychoactive Substance Use
- Ankle Trauma
- Lymphoblastic Lymphoma
- Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Refractory B-Lineage Lymphoma
- Stage III Childhood Anaplastic Large Cell Lymphoma
- Marginal Zone B-cell Lymphoma
- Hernia,Ventral
- Adherence to In-Office Glaucoma Evaluation Appointment
- Apneic; Oxygenation
- Spinocerebellar Ataxia Genotype Type 3
- View Full List
Drug Interventions
- Oral Aztreonam
- Everolimus
- Triple therapy
- Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
- Omeprazole 40 mg
- Optiva artificial tear by Allergan
- SBI-087
- LINjeta U-100 Insulin
- Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited
- Lansoprazole 15mg QD
- Low molecular weight Heparin as standard of care treatment
- Epalrestat
- Irinotecan
- ART-123
- Fostamatinib
- Gadoteridol (ProHance)
- Colecalciferol D3 (Vigantol Oil)
- FRSW107
- 300 mg of caffeine citrate infusion
- Fenofibric acid 135mg
- View Full List
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Dominican Republic
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Liberia
- Contract Research Organizations in Malawi
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Portugal
- Contract Research Organizations in Romania
- Contract Research Organizations in Slovakia
- Contract Research Organizations in South Africa
- Contract Research Organizations in Tanzania
- CRO list by country